Hypofractionated Postmastectomy Radiotherapy (HF-PMRT): What did We Learn from COVID-19 Era?

Hypofractionated Postmastectomy Radiotherapy (HF-PMRT): What did We Learn from COVID-19 Era?

Objectives: In breast cancer (BC) patients receiving mastectomy, postmastectomy radiotherapy (PMRT) improves long-term outcomes by decreasing local failure and cancer mortality. However, the optimal PMRT schedule is still under investigation. The present review aims to discuss the evidence regarding...

Full description

Bibliographic Details
Main Authors: Viola Salvestrini, Carlotta Becherini, Luca Visani, Isacco Desideri, Ilaria Morelli, Erika Scoccimarro, Cecilia Cerbai, Ilaria Bonaparte, Niccolo Bertini, Beatrice Bettazzi, Vieri Scotti, Marco Bernini, Lorenzo Orzalesi, Jacopo Nori, Simonetta Bianchi, Giulio Francolini, Icro Meattini, Lorenzo Livi
Format: Article
Language:English
Published: IMR Press 2023-02-01
Series:Clinical and Experimental Obstetrics & Gynecology
Subjects:
breast cancer
hypofractionated post-mastectomy radiotherapy
conventional fractionated pmrt
covid-19 pandemics
Online Access:https://www.imrpress.com/journal/CEOG/50/2/10.31083/j.ceog5002041

Internet

https://www.imrpress.com/journal/CEOG/50/2/10.31083/j.ceog5002041

Similar Items